Mythic Therapeutics

Developer of antibody-drug conjugates for the treatment of cancer

placeWaltham, Massachusetts, United States calendar_todayFounded 2017 groups12 employees language mythictx.com

Registered entities

Innovation

16 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,162 times.

YearFilings
20203
20214
20229
20233
20247
202510
20262

Social engagement

Social engagement: 6.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Viking Global Investors.

Investor typeCountShare
Venture capital1393%
Private equity17%

Recent activity

16 Oct 2025
Event
ESMO - European Society for Medical Oncology Congress 2025
22 Sep 2025
Leadership hire
Chief Medical Officer
12 Sep 2025
Milestone
anniversary
Coming soon